CATHERINE LUDLOW: Open Payments
NPI 1518007137 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 25 payments from 9 companies in 2025. Trend: 2023 $950 · 2024 $994 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $206 |
| Actelion Pharmaceuticals US, Inc. | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| Abbott Laboratories | 2 | $84 |
| Amgen Inc. | 2 | $46 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $40 |
| Boston Scientific Corporation | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: LEQVIO, UPTRAVI, CAMZYOS, REPATHA, ASSURITY, GALLANT, LifeVest, OPSUMIT.
Industry payments across FL — which companies pay providers there.
